Visit the Liberty Health Sciences Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Liberty Health Sciences Inc. Continues Expansion Strategy with Purchase of 36 Additional Acres of Florida Land at Chestnut Hill Tree Farm Site
Annual medical cannabis production capacity set to expand to 25,000 kgs by December 2019
TORONTO, Aug. 16, 2017 /CNW/ – Liberty Health Sciences Inc. (CSE:LHS) (OTCBB: SCQBD) (“Liberty” or the “Company”) announced today that the Company entered into a purchase and sale agreement to acquire an additional 36 acres of land in Alachua County, Florida (the “Transaction”) for $866,975.00 (USD) adjacent to their existing facility at Chestnut Hill Tree Farm. The purchase price paid in respect of the Transaction was funded from existing cash on hand. No additional permits or approvals are required in respect of the Transaction. The Company anticipates the Transaction closing on August 31, 2017.
This land purchase represents a key piece of our aggressive expansion plan in the State of Florida. Securing an additional 36 acres of land positions Liberty for exciting growth over the next 24 months to serve the growing demand for medical cannabis in Florida.
George Scorsis, CEO and Director of Liberty Health Sciences Inc.
According to state reports, Florida has seen a 60 per cent increase in the number of patients being treated with medical cannabis since June. Liberty expects this number to continue to grow exponentially due to more physicians recommending cannabis as a treatment option and an increase in qualifying medical conditions. The additional land will allow Liberty to increase production of medical cannabis over the next 18 months to meet growing patient demand and is expected to have a significant positive impact on local economic development in the north central region of Florida. Whereas the Company’s current facility consists of 13,000 square feet of growing space and produces 700 kgs annually, the Transaction represents Phase I of a three-part expansion process for Liberty:
Part I: Purchase of additional 36 acres of Florida land at Chestnut Hill Tree Farm site.
Part II: Immediately doubling output and constructing adjoining Greenhouses to increase annual medical cannabis production to 2,800kgs with an additional 33,000 square feet of growing space by January 2018.
Part III: Expected to increase annual medical cannabis production to 25,000kgs with 435,600 square feet of growing space by December 2019.
We’re extremely pleased with this land purchase. The extra space will go a long way to help meet the ever-growing demand for our high-quality, clean and safe pharmaceutical grade cannabis for Florida patients.
John Cervini, Director of Liberty Health Sciences Inc.
For more information on Liberty please visit www.libertyhealthsciences.com
About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. (“Liberty”) is an investor and operator in the medical cannabis market, capitalizing on new and existing opportunities in the United States. Liberty’s stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to patients.
Original press release: http://www.newswire.ca/news-releases/liberty-health-sciences-inc-continues-expansion-strategy-with-purchase-of-36-additional-acres-of-florida-land-at-chestnut-hill-tree-farm-site-640710053.html
The most reliable, fact-based information on Liberty Health Sciences found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.